E. Kurzius Lawrence's Insider Trades & SAST Disclosures
E. Kurzius Lawrence's most recent trade in McCormick & Co., Inc. - Ordinary Shares (Non Voting) was a trade of 1,734 Restricted Stock Units done . Disclosure was reported to the exchange on March 14, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern E. Kurzius Lawrence.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 1,734 | 3,469 | - | - | Restricted Stock Units | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 1,734 | 248,079 (2%) | 0% | 0 | Common Stock - Voting | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.18 per share. | 14 Mar 2025 | 642 | 247,437 (2%) | 0% | 80.2 | 51,476 | Common Stock - Voting |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Purchase of securities on an exchange or from another person at price $ 10.20 per share. | 07 Mar 2025 | 10,000 | 111,459 (0%) | 0% | 10.2 | 102,000 | Common Stock |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Purchase of securities on an exchange or from another person at price $ 10.90 per share. | 07 Mar 2025 | 10,000 | 101,459 (0%) | 0% | 10.9 | 109,000 | Common Stock |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.96 per share. | 18 Feb 2025 | 30,550 | 246,345 (2%) | 0% | 77.0 | 2,351,128 | Common Stock - Voting |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.96 per share. | 03 Feb 2025 | 50,000 | 326,895 (3%) | 0% | 50.0 | 2,498,000 | Common Stock - Voting |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director | Sale of securities on an exchange or to another person at price $ 76.81 per share. | 03 Feb 2025 | 50,000 | 276,895 (2%) | 0% | 76.8 | 3,840,320 | Common Stock - Voting |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 50,000 | 150,000 | - | - | Options - Right to Buy | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2025 | 77,637 | 276,895 (2%) | 0% | 0 | Common Stock - Voting | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director | Other type of transaction at price $ 0.00 per share. | 13 Jan 2025 | 198 | 31,626 | - | - | Phantom Stock | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 4,954 | 38,567 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Nov 2024 | 18,169 | 91,459 (0%) | 0% | 0 | Common Stock | |
| McCormick & Co., Inc. - Or... | E. Kurzius Lawrence | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2024 | 5,203 | 5,203 | - | - | Restricted Stock Units | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director | Other type of transaction at price $ 0.00 per share. | 21 Oct 2024 | 168 | 31,428 | - | - | Phantom Stock | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 4,084 | 33,612 | - | - | Deferred Stock Units | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director | Other type of transaction at price $ 0.00 per share. | 22 Jul 2024 | 177 | 31,259 | - | - | Phantom Stock | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Jul 2024 | 1 | 0 (0%) | 0% | 0 | Common Stock - Voting | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Jul 2024 | 1 | 0 (0%) | 0% | 0 | Common Stock - Voting | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 17 Jul 2024 | 25,000 | 0 (0%) | 0% | 75 | 1,875,000 | Common Stock - Non Voting |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director | Other type of transaction at price $ 0.00 per share. | 10 Jul 2024 | 25,000 | 25,000 (0%) | 0% | - | Common Stock - Non Voting | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director | Other type of transaction at price $ 0.00 per share. | 10 Jul 2024 | 25,000 | 0 (0%) | 0% | - | Common Stock - Voting | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 2,673 | 29,528 | - | - | Deferred Stock Units | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director | Sale of securities on an exchange or to another person at price $ 73.75 per share. | 22 Apr 2024 | 80,000 | 199,258 (2%) | 0% | 73.8 | 5,900,024 | Common Stock - Voting |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.14 per share. | 22 Apr 2024 | 80,000 | 279,258 (2%) | 0% | 38.1 | 3,051,600 | Common Stock - Voting |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2024 | 80,000 | 0 | - | - | Options - Right to Buy | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director | Other type of transaction at price $ 0.00 per share. | 22 Apr 2024 | 173 | 31,081 | - | - | Phantom Stock | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 1,689 | 26,855 | - | - | Deferred Stock Units | |
| McCormick & Co., Inc. - Or... | Kurzius Lawrence E. | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.99 per share. | 15 Feb 2024 | 25,744 | 199,258 (2%) | 0% | 65.0 | 1,673,231 | Common Stock - Voting |
| McCormick & Co., Inc. - Or... | Kurzius Lawrence E. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2024 | 65,423 | 225,002 (2%) | 0% | 0 | Common Stock - Voting | |
| McCormick & Co., Inc. - Or... | E. Lawrence Kurzius | Director | Other type of transaction at price $ 0.00 per share. | 08 Jan 2024 | 191 | 30,907 | - | - | Phantom Stock | |
| Elanco Animal Health Inc | E. Lawrence Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 1,845 | 25,165 | - | - | Deferred Stock Units | |
| Cooper Companies, Inc. | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2023 | 264 | 264 | - | - | Restricted Stock Units | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2023 | 20,374 | 73,290 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 2,446 | 23,320 | - | - | Deferred Stock Units | |
| McCormick & Co., Inc. - Or... | Kurzius Lawrence E. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2023 | 313,532 | 313,532 | - | - | Options - Right to Buy | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 2,733 | 20,873 | - | - | Deferred Stock Units | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.14 per share. | 12 May 2023 | 39,906 | 199,485 (2%) | 0% | 38.1 | 1,522,214 | Common Stock - Voting |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 90.02 per share. | 12 May 2023 | 39,906 | 159,579 (1%) | 0% | 90.0 | 3,592,378 | Common Stock - Voting |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2023 | 39,906 | 80,000 | - | - | Options- Right to Buy | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman & CEO | Other type of transaction at price $ 0.00 per share. | 24 Apr 2023 | 138 | 30,391 | - | - | Phantom Stock | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 2,925 | 18,140 | - | - | Deferred Stock Units | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 222,223 | 222,223 | - | - | Options- Right to Buy | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 7,970 | 163,242 (1%) | 0% | - | Common Stock - Voting | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 7,970 | 0 | - | - | Restricted Stock Units | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.78 per share. | 15 Mar 2023 | 3,663 | 159,579 (1%) | 0% | 71.8 | 262,930 | Common Stock - Voting |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Mar 2023 | 486 | 0 (0%) | 0% | 0 | Common Stock - Voting | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Mar 2023 | 486 | 0 (0%) | 0% | 0 | Common Stock - Voting | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.77 per share. | 13 Feb 2023 | 25,692 | 155,272 (1%) | 0% | 73.8 | 1,895,384 | Common Stock - Voting |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 750 | 15,214 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 18,649 | 52,916 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 712 | 14,464 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2022 | 694 | 13,752 | - | - | Deferred Stock Units | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Other type of transaction at price $ 0.00 per share. | 21 Oct 2022 | 5,000 | 5,000 (0%) | 0% | - | Common Stock - Non Voting | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Other type of transaction at price $ 0.00 per share. | 21 Oct 2022 | 5,000 | 123,898 (1%) | 0% | - | Common Stock - Voting | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 74.53 per share. | 21 Oct 2022 | 2,500 | 0 (0%) | 0% | 74.5 | 186,324 | Common Stock - Non Voting |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 74.30 per share. | 21 Oct 2022 | 2,500 | 2,500 (0%) | 0% | 74.3 | 185,750 | Common Stock - Non Voting |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 738 | 13,057 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 605 | 12,318 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2022 | 452 | 11,712 | - | - | Deferred Stock Units | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 57,066 | 180,964 (1%) | 0% | 0 | Common Stock - Voting | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Other type of transaction at price $ 0.00 per share. | 25 Jul 2022 | 145 | 30,113 | - | - | Phantom Stock | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Other type of transaction at price $ 0.00 per share. | 25 Jul 2022 | 138 | 30,252 | - | - | Phantom Stock | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Other type of transaction at price $ 0.00 per share. | 25 Jul 2022 | 130 | 29,968 | - | - | Phantom Stock | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 466 | 11,260 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 386 | 10,793 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 362 | 10,406 | - | - | Deferred Stock Units | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Apr 2022 | 2,209 | 0 (0%) | 0% | - | Common Stock - Voting | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Apr 2022 | 2,209 | 0 (0%) | 0% | - | Common Stock - Voting | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 351 | 10,044 | - | - | Deferred Stock Units | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2022 | 178,368 | 178,368 | - | - | Options- Right to Buy | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2022 | 7,966 | 132,559 (1%) | 0% | - | Common Stock - Voting | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2022 | 7,966 | 7,970 | - | - | Restricted Stock Units | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2022 | 6,994 | 127,807 (1%) | 0% | - | Common Stock - Voting | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2022 | 6,994 | 0 | - | - | Restricted Stock Units | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.99 per share. | 15 Mar 2022 | 3,661 | 128,898 (1%) | 0% | 97.0 | 355,080 | Common Stock - Voting |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.99 per share. | 15 Mar 2022 | 3,214 | 124,593 (1%) | 0% | 97.0 | 311,726 | Common Stock - Voting |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 322 | 9,692 | - | - | Deferred Stock Units | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.01 per share. | 13 Feb 2022 | 39,224 | 120,813 (1%) | 0% | 101.0 | 3,962,212 | Common Stock - Voting |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 352 | 9,370 | - | - | Deferred Stock Units | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 81,208 | 160,037 (1%) | 0% | 0 | Common Stock - Voting | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2021 | 323 | 9,018 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 7,307 | 34,267 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 318 | 8,695 | - | - | Deferred Stock Units | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2021 | 28,042 | 92,374 (0%) | 0% | - | Common Stock - Voting | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2021 | 28,042 | 0 | - | - | Restricted Stock Units | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.24 per share. | 27 Nov 2021 | 13,545 | 78,829 (0%) | 0% | 86.2 | 1,168,121 | Common Stock - Voting |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 217 | 8,376 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 224 | 8,158 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2021 | 214 | 7,933 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2021 | 196 | 7,718 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 206 | 7,522 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 199 | 7,315 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 226 | 7,116 | - | - | Deferred Stock Units | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Other type of transaction at price $ 0.00 per share. | 26 Apr 2021 | 110 | 29,074 | - | - | Phantom Stock | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Apr 2021 | 110,000 | 67,849 (0%) | 1% | - | Common Stock - Voting | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 220,589 | 220,589 | - | - | Options - Right to Buy | |
| Elanco Animal Health Inc | Lawrence E. Kurzius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 243 | 6,890 | - | - | Deferred Stock Units | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 8,502 | 0 | - | - | Restricted Stock Units | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 8,502 | 199,250 (2%) | 0% | - | Common Stock - Voting | |
| McCormick & Co., Inc. - Or... | Lawrence E. Kurzius | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 7,966 | 15,936 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges